JPS4941367A - - Google Patents

Info

Publication number
JPS4941367A
JPS4941367A JP5848173A JP5848173A JPS4941367A JP S4941367 A JPS4941367 A JP S4941367A JP 5848173 A JP5848173 A JP 5848173A JP 5848173 A JP5848173 A JP 5848173A JP S4941367 A JPS4941367 A JP S4941367A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5848173A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4941367A publication Critical patent/JPS4941367A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
JP5848173A 1972-05-25 1973-05-25 Pending JPS4941367A (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722226703 DE2226703A1 (de) 1972-05-25 1972-05-25 Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
JPS4941367A true JPS4941367A (https=) 1974-04-18

Family

ID=5846530

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5848173A Pending JPS4941367A (https=) 1972-05-25 1973-05-25

Country Status (12)

Country Link
JP (1) JPS4941367A (https=)
AT (1) AT323155B (https=)
AU (1) AU5607873A (https=)
BE (1) BE800066A (https=)
CA (1) CA1005062A (https=)
CH (1) CH582144A5 (https=)
CS (1) CS179416B2 (https=)
DD (1) DD106170A5 (https=)
DE (1) DE2226703A1 (https=)
FR (1) FR2185414B1 (https=)
GB (1) GB1436893A (https=)
NL (1) NL7307313A (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505148A (ja) * 2003-09-12 2007-03-08 エリクサー ファーマスーティカルズ インコーポレイテッド 疾患の治療法
JP2008513370A (ja) * 2004-09-13 2008-05-01 エリクシアー ファーマシューティカルズ, インコーポレイテッド 障害を処置する方法

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235903A (en) * 1979-08-06 1980-11-25 American Home Products Corporation 1-Hydroxyalkanamine tetrahydrocarbazoles and cyclopent[b]indoles, compositions and method of use
US6545034B1 (en) 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US7361680B2 (en) 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7129262B2 (en) 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7151100B1 (en) 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
DE10164564B4 (de) * 2001-12-14 2007-05-16 Zentaris Gmbh Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)
AU2003295336A1 (en) 2002-09-19 2004-04-08 Dennis A. Carson Use of etodoclac to treat hyperplasia
TW200524940A (en) * 2003-10-02 2005-08-01 Salmedix Inc Indole derivatives
US8580841B2 (en) * 2008-07-23 2013-11-12 Arena Pharmaceuticals, Inc. Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
HRP20160890T1 (hr) 2008-08-27 2016-09-23 Arena Pharmaceuticals, Inc. Derivati supstituirane tricikličke kiseline kao agonisti s1p1-receptora korisni u liječenju autoimunih i upalnih poremećaja
JP5856980B2 (ja) 2010-01-27 2016-02-10 アリーナ ファーマシューティカルズ, インコーポレイテッド (R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸およびその塩の調製のためのプロセス
CN105503882B (zh) 2010-03-03 2019-07-05 艾尼纳制药公司 制备s1p1受体调节剂及其晶体形式的方法
PL3242666T3 (pl) 2015-01-06 2025-02-17 Arena Pharmaceuticals, Inc. Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
BR112017027656B1 (pt) 2015-06-22 2023-12-05 Arena Pharmaceuticals, Inc. Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
MX2019009841A (es) 2017-02-16 2020-01-30 Arena Pharm Inc Compuestos y metodos para el tratamiento de la colangitis biliar primaria.
MX2019009843A (es) 2017-02-16 2020-01-30 Arena Pharm Inc Compuestos y metodos para el tratamiento de la enfermedad inflamatoria intestinal con manifestaciones extraintestinales.
CA3102136A1 (en) 2018-06-06 2019-12-12 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the s1p1 receptor
CN112955431A (zh) 2018-09-06 2021-06-11 艾尼纳制药公司 可用于治疗自身免疫性病症和炎性病症的化合物
CN114634442B (zh) * 2022-04-02 2023-10-13 内蒙古民族大学 一种四氢咔唑酮化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH586678A5 (https=) * 1970-05-25 1977-04-15 Hoffmann La Roche
ZA715217B (en) * 1970-08-20 1972-04-26 Org Nv Anti-inflammatory preparations

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505148A (ja) * 2003-09-12 2007-03-08 エリクサー ファーマスーティカルズ インコーポレイテッド 疾患の治療法
JP2008513370A (ja) * 2004-09-13 2008-05-01 エリクシアー ファーマシューティカルズ, インコーポレイテッド 障害を処置する方法

Also Published As

Publication number Publication date
AT323155B (de) 1975-06-25
NL7307313A (https=) 1973-11-27
AU5607873A (en) 1974-11-28
CH582144A5 (https=) 1976-11-30
CA1005062A (en) 1977-02-08
DD106170A5 (https=) 1974-06-05
FR2185414B1 (https=) 1976-08-13
DE2226703A1 (de) 1973-12-13
BE800066A (fr) 1973-11-26
FR2185414A1 (https=) 1974-01-04
GB1436893A (en) 1976-05-26
CS179416B2 (en) 1977-10-31

Similar Documents

Publication Publication Date Title
CS166174B2 (https=)
CS178199B2 (https=)
CS158495B1 (https=)
CS160075B2 (https=)
CU33821A (https=)
CH569984A5 (https=)
CH1798272A4 (https=)
BG18459A1 (https=)
BG18484A1 (https=)
BG18503A1 (https=)
BG18508A1 (https=)
BG18550A1 (https=)
BG18743A1 (https=)
BG19234A1 (https=)
BG19419A1 (https=)
BG19715A1 (https=)
BG19862A1 (https=)
BG21593A3 (https=)
CH584677A5 (https=)
CH1773873A4 (https=)
CH580074A5 (https=)
CH249673A4 (https=)
CH561697A5 (https=)
CH565657A5 (https=)
DD106170A5 (https=)